These are the symptoms of colorectal cancer. Learn about its causes, risks, and the importance of early detection.
The observational study measured how physicians changed treatment plans after seeing HER2DX results and how patients did on the new plans.
Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced four preclinical poster presentations at ...
*During data validation and verification for the manuscript, one patient that was originally reported as having a response in the 2021 AACR Annual Meeting presentation of this cohort was found instead ...
Methods: Here, we assess the efficacy of clinically usable CAR-engineered NK cell line NK-92/5.28.z against ErbB2-positive RMS in vitro and in a metastatic xenograft mouse model. Results: Our results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results